#United States #Los Angeles #Clinical Trials #Ryght AI #Keck School

Ryght AI Launches Global Clinical Trial Site Network

In a groundbreaking announcement, Ryght AI, a pioneering company focused on AI technology for healthcare, unveiled its new initiative called 'The Ryght Research Network'. This global network aims to enhance the efficiency of clinical trials by integrating a wide range of academic institutions and healthcare providers, with the University of Southern California's Keck School of Medicine as its inaugural academic site.

The Importance of Efficient Clinical Trials

Clinical trials are crucial for the advancement of medical knowledge and the development of new therapies. However, they often suffer from inefficiencies created by outdated practices and excessive manual tasks. It is reported that about 30% of Clinical Research Associates leave their roles due to burnout. In oncology research, a staggering 80% of programs experience staffing shortages, leading to significant administrative burdens. Consequently, many trial sites fail to enroll even a single patient, delaying critical therapies and increasing the likelihood of trial failures. Ryght AI aims to solve these pressing challenges by leveraging the capabilities of generative AI.

Leveraging AI for Clinical Research

David Friedland, M.D, Ph.D., from the Keck School of Medicine, emphasized the transformative potential of the Ryght Research Network: "By streamlining site selection, feasibility, and patient referrals, we can focus more on advancing patient care and less on administrative burdens. This partnership brings us closer to our goal of innovative and efficient research that improves global health outcomes."

The Ryght Research Network connects a diverse range of healthcare facilities, from small clinics to large academic institutions, with clinical trial sponsors. By harnessing the power of real-time data analysis and advanced AI algorithms, the network aims to deliver actionable insights that can streamline trial management processes. This includes automating tasks such as feasibility assessments and patient referrals, which traditionally consume a large portion of researchers' time.

Real-World Impact on Research Operations

The Ryght AI initiative represents a significant shift in how clinical trials will be conducted in the future. By facilitating real-time communications between various stakeholders, the platform aims to accelerate the overall process of clinical trials. It positions itself as a comprehensive solution, ensuring that all involved parties have access to vital information to make informed decisions quickly and efficiently.

Chadi Nabhan, MD, MBA, Chief Medical Officer at Ryght, stated, "We are excited to welcome USC to our network. Together, we aim to expedite trial processes that will enhance the outcomes for patients, particularly those affected by cancer."

Commitment to Data Security and Integrity

As clinical trials increasingly rely on data-driven decision-making, Ryght AI places a strong emphasis on maintaining data integrity and security. Their platform is built to optimize the use of multiple large language models (LLMs), ensuring that sensitive information remains protected while still being utilized to the fullest extent to drive research outcomes.

Looking Ahead: The Future of Clinical Trials

The launch of the Ryght Research Network is set to redefine the landscape of clinical research. By fostering collaborations between varied healthcare providers and leveraging the advancements in AI technology, Ryght AI is leading a movement towards more efficient, transparent, and successful clinical trials. This proactive approach not only helps researchers and sponsors but ultimately benefits patients waiting for new treatments to reach the market more quickly.

For those interested in learning more about Ryght AI and their innovative solutions for the clinical research industry, please visit their official website at www.ryght.ai.